Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML

NCT00416884 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low enrollment

Conditions

Leukemia

Interventions

DRUG: Campath
DRUG: Fludarabine
RADIATION: Total Body Irradiation (TBI)
OTHER: T-Cell Deplete

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]